Active — Not RecruitingNot Applicable

Guideline-directed Management and Therapy (GDMT) for the Prevention of Postpartum Cardiac Dysfunction in Preeclamptic African American Women

United States20 participantsStarted 2022-10-27

Plain-language summary

This is a single-center, open-label pilot study looking at how Guideline-directed management and therapy (GDMP) in post-partum women with preeclampsia can improve Global Longitudinal Strain (GLS).

Who can participate

Age range18 Years – 45 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Adults between 18 and 45 years of age
✓. African American
✓. \>120/80 BP at the time of their 6-month visit in the PARENT study
✓. Diagnosed with preeclampsia
✓. Initially presented to University of Chicago Medical Center (UCMC) for a Singleton Gestation Delivery
✓. Completed the 6 month visit in the PARENT study

Exclusion criteria

✕. Those who cannot provide consent
✕. patients with preexisting cardiomyopathy, ischemic or valvular heart disease, pulmonary disease, diabetes mellitus, chronic kidney disease, multiple gestations,
✕. Unable to operate the RPM tablet device

What they're measuring

GLS percentages

Timeframe: 3 Months

Trial details

NCT IDNCT05534932

SponsorUniversity of Chicago

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2026-07-01

View on ClinicalTrials.gov More Preeclampsia Postpartum trials